---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-152044"
form_type: "8-K"
ticker: "CGON"
cik: "0001991792"
company_name: "CG Oncology, Inc."
filed_at: "2026-04-13T23:59:59+00:00"
generated_at: "2026-05-15T06:37:37.600440+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# CG Oncology appoints Jim DeTore as CFO with $520K base and $5M equity

## Summary
- Jim DeTore, age 61, appointed CFO effective April 13, 2026; previously served as interim principal financial officer since Nov 2025.
- Initial annual base salary of $520,000 with target bonus of 45% of base salary.
- Equity grants: $4M stock option (4-year vest, 25% one-year cliff) and $1M PSU award (vesting on first U.S. commercial sale and positive operating cash flow).
- Severance includes 12 months base salary and COBRA for non-CIC terminations; 1.5x base salary and full vesting for CIC terminations.
- DeTore reports to CEO and will work remotely from Boston area.

## SEC filing metadata
- accession: 0001193125-26-152044
- form_type: 8-K
- ticker: CGON
- cik: 0001991792
- company_name: CG Oncology, Inc.
- filed_at: 2026-04-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1991792/000119312526152044/0001193125-26-152044-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1991792/000119312526152044/ck0001991792-20260413.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-152044
- JSON: https://secwatch.observer/filing/0001193125-26-152044.json
- Plain text: https://secwatch.observer/filing/0001193125-26-152044.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.